Dr. Mary Horowitz Presented with Lifetime Achievement Award for Blood and Marrow Transplant Research|
Mary Horowitz, MD, MS, the Robert A. Uihlein, Jr. Chair in Hematologic Research, professor of medicine and chief of hematology and oncology at the Medical College of Wisconsin, was presented with the 2014 Lifetime Achievement Award by the American Society for Blood and Marrow Transplantation. [Medical College of Wisconsin]
Cord Blood Registry’s Newborn Possibilities Program
For families that have been identified with a qualifying medical condition currently treatable with a cord blood stem cell transplant or a high-risk pregnancy, the Newborn Possibilities Program provides no-cost newborn stem cell processing and five years of storage. [PR Newswire Association LLC]
Cesca Therapeutics Submits Pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System
Cesca Therapeutics, Inc., an autologous cell based regenerative medicine company, announced it has submitted a pre-IDE (Investigational Device Exemption) information package to the U. S. Food and Drug Administration (FDA) for the use of the SurgWerks™ CLI Therapy designed to treat no option patients with late stage critical limb ischemia (CLI). [GlobeNewswire, Inc.]
From our sponsor:
View immunology lectures, protocols and other resources on the Human Immunology Portal.